Conference Scene: Personalized Medicine in Europe.
The translation of personalized medicine into clinical practice is proving to be quite challenging, with numerous stakeholders all reliant on its success. A key aspect to its success is the timely creation and launch of companion diagnostics that can help implement personalized medicine into the clinic. In this article, I report from the Personalised Medicine and Diagnostics Europe 2011 industry conference, which was held on 9-10 March 2011 at the Novotel, St Pancras, London, UK. This industry conference was well attended with a primarily European pool of delegates representing the biotechnology and pharmaceutical companies, the technology/diagnostic developers and regulators, as well as the academic research community. This conference represented the current state of affairs with respect to personalized medicine and diagnostics in Europe.